Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

buy

Acadia Pharmaceuticals buy Citigroup Inc.

Acadia Pharmaceuticals

Start price

€18.83

/ 50%

Target price

08.05.27

Performance (%)

Price

Summary

This prediction is currently active. With a performance of , the BUY prediction by Citigroup_Inc_ is trending in the wrong direction. This prediction currently runs until 08.05.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this prediction

Performance without dividends (%)

Name	1w
Acadia Pharmaceuticals
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by Citigroup_Inc_ for this prediction

In the thread Acadia Pharmaceuticals diskutieren

Prediction Buy

Perf. (%)

Target price 27.286

Change

Ends at

ACADIA Pharmaceuticals (ACAD) had its price target lowered by Citigroup Inc. from $33.00 to $32.00. They now have a "buy" rating on the stock.

Ratings data for ACAD provided by MarketBeat

0

Stopped prediction by Citigroup_Inc_ for Acadia Pharmaceuticals

Acadia Pharmaceuticals

Start price

Target price

Perf. (%)

€20.40

07.08.26

50%

Acadia Pharmaceuticals

Start price

Target price

Perf. (%)

€14.56

08.08.25

50%

Acadia Pharmaceuticals

Start price

Target price

Perf. (%)

€14.59

09.05.25

50%

Acadia Pharmaceuticals

Start price

Target price

Perf. (%)

€20.00

13.12.24

50%